Connectome Health raises 2 million USD pre-seed round
Zurich-based neurotech startup Connectome Health has secured 2 million USD in a pre-seed funding round. The investment includes 120,000 USD in non-dilutive public funding. The round was led by Redstone with participation from Transatlantic Angels, Concept Ventures, and Octopus Ventures.
Founded in 2024 by neuroscientists Scherdel and Dr. Rufus Mitchell-Heggs, Connectome Health focuses on longitudinal tracking of brain activity. By collecting neural signals alongside daily context such as sleep and behavioral load, the company aims to develop personalized baselines for identifying cognitive changes. The founders bring significant experience from consumer health and global research sectors to the venture.
The capital will be used to support the rollout of the company platform with select partners and to further research and development efforts. Furthermore, Connectome Health plans to expand its scope beyond lifestyle and wearable integration into broader diagnostic applications.
Zurich-based neurotech startup Connectome Health has secured 2 million USD in a pre-seed funding round. The investment includes 120,000 USD in non-dilutive public funding. The round was led by Redstone with participation from Transatlantic Angels, Concept Ventures, and Octopus Ventures.
Founded in 2024 by neuroscientists Scherdel and Dr. Rufus Mitchell-Heggs, Connectome Health focuses on longitudinal tracking of brain activity. By collecting neural signals alongside daily context such as sleep and behavioral load, the company aims to develop personalized baselines for identifying cognitive changes. The founders bring significant experience from consumer health and global research sectors to the venture.
The capital will be used to support the rollout of the company platform with select partners and to further research and development efforts. Furthermore, Connectome Health plans to expand its scope beyond lifestyle and wearable integration into broader diagnostic applications.